First Line Chemotherapy Treatment of Advanced NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00308750
Recruitment Status : Completed
First Posted : March 30, 2006
Last Update Posted : June 2, 2010
Information provided by:
Eli Lilly and Company